Inside Mastercard’s Earnings Call: Growth, Headwinds and the Next Likely Move
Mastercard reported growth while stressing headwinds and heavy buybacks. The next concrete move is most likely a fresh repurchase authorization.
Tag • 12 articles
Companies & Deals
Articles currently tagged Companies & Deals.
Crypto Firms Pivot From Hype to Discipline as Earnings Reset Expectations
Recent earnings show major crypto companies emphasizing cost control, recurring revenue and risk management over raw trading hype.
SBI’s Q4 profit inches up 6% as board backs Rs 17.35 dividend
State Bank of India posts modest Q4FY26 profit growth and announces a Rs 17.35 dividend. The next key move is likely to be around capital allocation.
Rocket Lab’s Record High Puts Focus on Its Next Concrete Move
Rocket Lab beat Q1 2026 expectations and signed its biggest launch deal yet. The next confirmed decision now looms as the key test of its momentum.
Could the Supreme Court Step Into NCAA Athlete Eligibility Rules?
A guest commentary asks if the US Supreme Court will decide NCAA athlete eligibility. Here is what is known, what is at stake, and what could come next.
Tim Cook hails Apple’s $111.2bn quarter as revenue beats forecasts
Apple’s first results since announcing Tim Cook’s planned exit show $111.2bn in revenue, easily topping Wall Street expectations.
XORTX Closes Vectus Kidney Asset Deal: What Likely Comes Next
With the Vectus kidney asset acquisition now closed, the next concrete move from XORTX is likely a formal integration and development plan.
What Synchrony’s Q4 Earnings Signal in a Crowded Card Market
Synchrony Financial’s Q4 results are being weighed directly against peers. Here’s what that comparison reveals—and what it doesn’t.
SpaceX Reportedly Eyes IPO Valuation Above $2 Trillion
Bloomberg and other outlets report SpaceX is targeting an IPO valuation above $2 trillion, a level that would eclipse any previous stock market debut.
Stronger US Retail Sales Test the ‘Tired Consumer’ Narrative
February’s retail rebound suggests US shoppers still have fuel, with Amazon and other online giants poised to benefit if the momentum holds.
Why Trump’s MAHA Base Is Restless Over Undelivered Pharma Crackdowns
A new POLITICO poll shows strong public appetite to confront big drug makers—yet Trump’s actions so far fall short of what many MAHA supporters expected.
Why MAHA Loyalists Say Trump Hasn’t Delivered on Big Pharma
A new POLITICO poll shows strong public appetite for confronting drug makers. Trump’s MAHA base wants more action than they believe he has delivered.